Compare StocksMS vs TMO

Morgan Stanley (MS) vs Thermo Fisher Scientific Inc. (TMO): Which Is the Better Buy in 2026?

As of 2026-06-19, MS is undervalued at $223, with a DCF intrinsic value of $298 and a margin of safety of 25%. TMO is overvalued at $465, with an intrinsic value of $407 and a margin of safety of -14%. Of the two, MS has the wider margin of safety.

MS
Morgan Stanley
$223.17
VS
TMO
Thermo Fisher Scientific Inc.
$464.61

Rewards

MS
  • Gross margin of 87.4% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.
TMO
  • Trailing P/E of 25.5x is 21% below the historical average of 32.3x — potentially undervalued relative to its own history.
  • Altman Z-Score of 3.85 indicates very low bankruptcy risk — the company is firmly in the safe zone.

Risks

MS
  • Trailing P/E of 20.2x is 26% above the historical average of 16.1x — the stock trades at a premium to its own history.
  • PEG ratio of 2.66 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
TMO
  • 21 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
MS
TMO
Valuation
N/A
Free Cash Flow
$5.52B
N/A
FCF Yield
3.20%
20.21
Trailing P/E
25.53
17.56
Forward P/E
17.05
Quality & Moat
3.38%
ROIC
6.71%
16.39%
ROE
13.52%
87.39%
Gross Margin
40.93%
2.66
PEG Ratio
1.55
Balance Sheet Safety
Net cash
Net Debt / Equity
0.77
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
3.53
1.81%
Dividend Yield
0.40%
MS: 5Ties: 2TMO: 2
MSTMO

Historical Fundamentals

Learn more →
MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TMO

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TMO
$0.17
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$17.29B
Δ Market Cap
+$2.95B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
MS
25.0% Margin of Safety
Price is 25.0% below estimated fair value
Current Price: $223.17
Fair Value: $297.53
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TMO
14.3% Overvalued
Price is 14.3% above estimated fair value
Current Price: $464.61
Fair Value: $406.54
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
MS

Requires positive FCF to compute implied growth rate.

TMO

What growth rate is the market pricing in at $465?

+11.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.6%

The market implies +11.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
TMO
60/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TMO
-2.47
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
MS
Insiders 24.3%Institutions 62.8%Retail & Other 12.9%
No. of Institutional Holders3,208
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TMO
Insiders 0.2%Institutions 94.3%Retail & Other 5.6%
No. of Institutional Holders3,536
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
MS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $5,630
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises
TMO
0
Buys (3M)
0
Buys (12M)
CHAI NELSON J
Director
$11,038
@ $551.90 · 2024-12-09
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
MS
4
Sells (3M)
16
Sells (12M)
Total value (12M): $70.42M
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
CRAWLEY MANDELL L.
Officer
$368,375
@ $105.25 · 2024-07-26
AKRAM RAJA
Officer
$797,764
@ $106.37 · 2024-07-18
HERZ ROBERT H
Director
$106,621
@ $106.62 · 2024-07-17
SIMKOWITZ DANIEL A
President
$4.26M
@ $106.54 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TMO
1
Sells (3M)
21
Sells (12M)
Total value (12M): $110.57M
PETTITI GIANLUCA
President
$185,064
@ $462.66 · 2026-04-27
SHAFER MICHAEL D
Officer
$802,536
@ $499.40 · 2026-03-11
CASPER MARC N
Chief Executive Officer
$2.06M
@ $514.82 · 2026-03-05
CASPER MARC N
Chief Executive Officer
$5.08M
@ $507.75 · 2026-03-04
PETTITI GIANLUCA
Officer
$216,480
@ $541.20 · 2026-02-09
LAGARDE MICHEL
Chief Operating Officer
$12.42M
@ $563.56 · 2025-12-04
LAGARDE MICHEL
Chief Operating Officer
$36.13M
@ $582.68 · 2025-12-03
LOWERY FREDERICK M.
Officer
$8.15M
@ $589.81 · 2025-12-02
SHAFER MICHAEL D
Officer
$6.43M
@ $600.00 · 2025-11-25
LAGARDE MICHEL
Chief Operating Officer
$2.76M
@ $594.42 · 2025-11-13
BRITT LISA P
Officer
$622,136
@ $588.59 · 2025-11-12
PETTITI GIANLUCA
Officer
$1.73M
@ $580.00 · 2025-11-10
BRITT LISA P
Officer
$5.84M
@ $571.62 · 2025-11-07
CASPER MARC N
Chief Executive Officer
$13.91M
@ $571.33 · 2025-10-27
PETTITI GIANLUCA
Officer
$229,660
@ $574.15 · 2025-10-24
CASPER MARC N
Chief Executive Officer
$200,201
@ $500.50 · 2025-09-05
HOLMES JOSEPH R.
Officer
$189,662
@ $492.63 · 2025-08-29
CASPER MARC N
Chief Executive Officer
$5.01M
@ $500.96 · 2025-08-22
CASPER MARC N
Chief Executive Officer
$248,046
@ $500.09 · 2025-08-20
CASPER MARC N
Chief Executive Officer
$8.15M
@ $452.99 · 2025-08-07
PETTITI GIANLUCA
Officer
$191,992
@ $479.98 · 2025-07-25
PETTITI GIANLUCA
Officer
$164,444
@ $411.11 · 2025-05-12
PETTITI GIANLUCA
Officer
$128,979
@ $429.93 · 2025-04-28
BOXER MICHAEL A
General Counsel
$2.01M
@ $532.59 · 2025-03-10
CASPER MARC N
Chief Executive Officer
$9.33M
@ $518.16 · 2025-03-05
SHAFER MICHAEL D
Officer
$945,038
@ $530.92 · 2025-03-03
LOWERY FREDERICK M.
Officer
$9.73M
@ $531.81 · 2025-02-24
CHAI NELSON J
Director
$8,449
@ $528.06 · 2025-02-19
WILLIAMSON STEPHEN
Chief Financial Officer
$11.58M
@ $589.36 · 2025-02-04
PETTITI GIANLUCA
Officer
$175,677
@ $585.59 · 2025-02-04
CASPER MARC N
Chief Executive Officer
$10.62M
@ $531.23 · 2024-12-03
CASPER MARC N
Chief Executive Officer
$3.26M
@ $557.89 · 2024-11-01
CASPER MARC N
Chief Executive Officer
$11.01M
@ $550.51 · 2024-10-31
CASPER MARC N
Chief Executive Officer
$11.05M
@ $552.46 · 2024-10-29
PETTITI GIANLUCA
Officer
$168,048
@ $560.16 · 2024-10-25
BOXER MICHAEL A
General Counsel
$1.12M
@ $560.16 · 2024-10-25
CASPER MARC N
Chief Executive Officer
$12.17M
@ $608.45 · 2024-09-04
CASPER MARC N
Chief Executive Officer
$6.17M
@ $617.21 · 2024-07-31
CASPER MARC N
Chief Executive Officer
$9.88M
@ $606.12 · 2024-07-30
PETTITI GIANLUCA
Officer
$180,255
@ $600.85 · 2024-07-26
HOLMES JOSEPH R.
Officer
$525,484
@ $611.03 · 2024-07-26
BRITT LISA P
Officer
$2.22M
@ $613.02 · 2024-07-26
BOXER MICHAEL A
General Counsel
$1.20M
@ $600.85 · 2024-07-26
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
MS
FearGreed
😏Greed(70/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TMO
FearGreed
😨Fear(40/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
MS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
TMO
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (40)
View MS Full AnalysisView TMO Full Analysis

Frequently Asked Questions: MS vs TMO

Is Morgan Stanley or Thermo Fisher Scientific Inc. more undervalued in 2026?

Based on our discounted cash flow model, MS trades at a 25.0% margin of safety (intrinsic value $298 vs. price $223), compared to TMO's -14.3% margin of safety (intrinsic $407 vs. $465).

Which stock has a wider economic moat, Morgan Stanley or Thermo Fisher Scientific Inc.?

MS scores 80/100 (Wide moat), while TMO scores 60/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. TMO scores 3.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Morgan Stanley or Thermo Fisher Scientific Inc.?

TMO earns 6.7% ROIC versus MS's 3.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Morgan Stanley's or Thermo Fisher Scientific Inc.'s?

TMO's dividend earns a safety score of 94/100 (Very Safe), compared to MS's 79/100 (Safe). TMO has raised its dividend for 3 consecutive years.

MS vs TMO: Which Is the Better Buy in 2026? | SafetyMargin.io